Merck Solidifies RCC Position, While Bristol Gets Good SubQ Readout

 
• By Joseph Haas
  
Merck_New_Jersey
Merck demonstrates an overall survival benefit with Keytruda in RCC
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Strategy

More from Business